首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1931112篇
  免费   149650篇
  国内免费   23585篇
耳鼻咽喉   23645篇
儿科学   57727篇
妇产科学   48980篇
基础医学   270768篇
口腔科学   52711篇
临床医学   185936篇
内科学   365017篇
皮肤病学   40805篇
神经病学   144453篇
特种医学   72889篇
外国民族医学   440篇
外科学   279773篇
综合类   81724篇
现状与发展   77篇
一般理论   558篇
预防医学   138206篇
眼科学   47862篇
药学   150182篇
  299篇
中国医学   19843篇
肿瘤学   122452篇
  2021年   25216篇
  2020年   18416篇
  2019年   22478篇
  2018年   29257篇
  2017年   23459篇
  2016年   24415篇
  2015年   30766篇
  2014年   40711篇
  2013年   49994篇
  2012年   70680篇
  2011年   76142篇
  2010年   45392篇
  2009年   40416篇
  2008年   64242篇
  2007年   67587篇
  2006年   68307篇
  2005年   65931篇
  2004年   58597篇
  2003年   55408篇
  2002年   52445篇
  2001年   96677篇
  2000年   99237篇
  1999年   83533篇
  1998年   24211篇
  1997年   21773篇
  1996年   19943篇
  1995年   20060篇
  1994年   18047篇
  1993年   15896篇
  1992年   59261篇
  1991年   56889篇
  1990年   54342篇
  1989年   51900篇
  1988年   47081篇
  1987年   45700篇
  1986年   42799篇
  1985年   40472篇
  1984年   29583篇
  1983年   24996篇
  1982年   13917篇
  1979年   25534篇
  1978年   17528篇
  1977年   14849篇
  1976年   13829篇
  1975年   14513篇
  1974年   17601篇
  1973年   16907篇
  1972年   15664篇
  1971年   14433篇
  1970年   13415篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
Hepatocellular carcinoma (HCC) ranks the sixth place of most common cancers. Meanwhile, it is the tertiary mortality cause of cancer. There is no effective therapeutic method to prevent and treat the liver cancer. Sinomenine is a kind of Chinese traditional medicine herbal, it is reported that it can inhibit the viability of several cancer cells. The study is to explore whether sinomenine is also able to inhibit the cell viability of HCC and its potential mechanism. The IC50 of sinomenine in BEL-7402 cells was 5.351 mmol/L, and the IC50 of sinomenine in SMMC-7721 cells was 6.204 mmol/L. The gene expression results showed the relative expression of FGF2, CCND2, DCN, F3, MMP7, NRG1, HMGB1, TRIM29, HAS2, EHF, CTGF, PLK2 were down-regulated, and the relative expression of VEGF A, CITED2, NUPR1, DDX58, IRF9, NAMPT, MMP1, NDRG1, HMGA2, PPARGC1A, IFIT2, PARP9, HEY1, LOX, ETV1, ISG15, BACH, CYLD were up-regulated. Moreover, the IPA analysis results suggested that IFIT3, IFIT1, OAS1, MX1, IRF9, IFI6, IFITM1, ISG15 were up-regulated in BEL-7402 cells treated with sinomenine by activating IFNA2. The findings presented in this study may provide a promising method for the prevention and treatment of liver cancer.  相似文献   
73.
74.
75.
Objective: The survival rates of breast cancer are increasing as screening and diagnosis improve. The removal of noise is revealed to be a significant step for automatic - computer aided detection (CAD) of microcalcification in digital mammography. Methods: In this paper, a combined approach for eradicating impulse noise from digital mammograms is proposed. The process is achieved in two stages, detection of noise followed by filtering of noise. The detection of noise is carried out by using Modified Robust Outlyingness Ratio (mROR) trailed by an extended NL (Non-Local)-means filter for filtering mechanism. Results: According to the value of mROR, all pixels in mammogram images are divided into four distinct groups. In each cluster, many decision rules are then applied for detecting the impulse noise. Filtering is done with NL-means filter by providing a reference mammogram image. Conclusion: The comparative analysis and evaluated results are compared with some existing filters which indicate that the proposed structure outperforms the analysed result of others.  相似文献   
76.
miRNAs是一类长度约为20~25个核苷酸,参与基因调控表达的内源性非编码RNA。miR-149作为miRNAs的重要成员,在多种肿瘤中表达异常,其表达水平与肿瘤细胞增殖、转移、凋亡、耐药、患者的早期诊断及预后密切相关。因此,miR-149有望成为新一类抗肿瘤治疗的靶点。  相似文献   
77.
Objective: Human epidermal growth factor receptor 2 (erbb2/HER2) overexpression, has now been implicatedin advanced gastric and gastroesophageal junction cancers. The study was conducted to determine the rate of HER2positivity in patients with locally advanced or metastatic gastric and gastroesophageal adenocarcinoma in North-EastIndia and to assess the impact of various demographic and clinical parameters on HER2 positivity. Methods: A total of68 patients of age >18 years of gastric and gastroesophageal adenocarcinoma diagnosed on histopathological examinationfrom September 2016 to February 2018 at Dr B Borooah Cancer Institute, Assam were enrolled for the observational(epidemiological) study. All patients were subjected to the HER2 immunohistochemistry test using a FDA-approved,standardized test kit. HER2 expression was correlated with various demographic and clinicopathological parameters.Results: The overall rate of HER2 positivity in the population studied was 56% (n=38). The rate was non-significantlyhigher in male, older age group (>60 years) and Hindu population. Similarly, HER2 positivity rate was higher in patientswith well differentiated histology and was more common in patients with stage II and III diseases, but neither of theassociations is statistically significant. HER2 positivity rate was significantly higher in proximal and in GEJ tumours(56% versus 44%, P=0.002). Conclusion: HER2 overexpression was evident in 56% of the North-East Indian patientswith locally advanced and metastatic gastric and gastroesophageal adenocarcinoma. The overexpression correlatedsignificantly with primary tumour site. Routine testing of gastric and gastroesophageal tumours for HER2 expressionis recommended to provide a therapeutic advantage in Indian patients.  相似文献   
78.
79.
80.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号